Understanding how lung cancer develops and interacts with the immune system
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
This research aims to understand the very first steps of lung adenocarcinoma development and how it interacts with the body's immune system.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11135449 on NIH RePORTER |
What this research studies
Lung adenocarcinoma is a common and serious type of lung cancer, and while early detection is improving, we still don't fully understand what causes it to start in a specific area of the lung. This project looks closely at how different cells in the lung, including immune cells, change and interact over time and space as lung cancer begins to form. By studying these early changes in human samples, we hope to uncover the key events that drive the disease. This deeper understanding could help us find new ways to stop lung cancer before it becomes advanced.
Who could benefit from this research
Good fit: Patients with lung adenocarcinoma, especially those diagnosed at early stages, or individuals at high risk for the disease, could eventually benefit from this research.
Not a fit: Patients with advanced lung cancer or other cancer types may not directly benefit from this specific early-stage development research.
Why it matters
Potential benefit: If successful, this work could lead to new strategies for early detection and prevention of lung adenocarcinoma, potentially improving outcomes for many patients.
How similar studies have performed: While preliminary efforts have shown promising insights into cellular changes, this project aims for a novel, more comprehensive understanding of the spatial and temporal co-evolution of tumor and immune cells in early lung cancer.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Kadara, Humam — University of Tx Md Anderson Can Ctr
- Study coordinator: Kadara, Humam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.